Monro, Sylvius, Magendie, and Luschka are:

Map brain, percutaneous endoscopic approach

A) 0DN64ZZ B) 0DN94ZZ C) 00K04ZZ D) 00K94ZZ

Which of the following is descriptive of the Centers for Disease Control and Prevention classification of biosafety level 2 (BSL2)?

A) Agents are not known to cause diseases consistently in healthy adults. B) Dangerous/exotic agents pose high risk of life-threatening disease and aerosol-transmitted lab infections. C) Indigenous or exotic agents with potential for aerosol transmission cause diseases that may have serious or lethal consequences. D) Agents are associated with human disease; hazards by percutaneous injury, ingestion, and mucous membrane exposure.